Nicotine Metabolite Quantitative – Serum Test

The Nicotine Metabolite Quantitative – Serum test measures nicotine exposure by detecting and quantifying nicotine and one or more of its metabolites in a serum sample. The principal metabolite used for this purpose is cotinine. Cotinine remains in the body longer than nicotine and is therefore a more reliable biomarker of recent exposure.

Nicotine may enter the body through cigarettes, bidis, cigars, pipes, smokeless tobacco, nicotine-containing e-cigarettes or vaping products, nicotine pouches and nicotine-replacement products such as patches, gum and lozenges. The test can demonstrate recent nicotine exposure, but it may not independently identify which product produced the result.

Quantitative serum nicotine-metabolite testing may be used to assess recent nicotine exposure, support a smoking-cessation programme, document abstinence before selected surgical procedures or organ transplantation, or evaluate possible environmental tobacco-smoke exposure. Results must be interpreted according to the time since last exposure, the product used, individual metabolism and the laboratory's analytical method.

What Are Nicotine and Cotinine?

Nicotine is an addictive chemical naturally present in tobacco plants. When inhaled, absorbed through the mouth or delivered through the skin, it reaches the bloodstream and stimulates nicotinic receptors. It can increase alertness, heart rate and blood pressure and contributes to dependence by affecting dopamine pathways in the brain.

The liver rapidly metabolises nicotine, primarily through enzymes including CYP2A6. Cotinine is one of the major products of this metabolism. Nicotine has a relatively short elimination half-life of approximately two hours, whereas serum cotinine generally has a half-life of about 15 to 24 hours. Cotinine therefore remains detectable longer and gives a more stable indication of recent nicotine exposure.

Individual cotinine concentrations vary according to the amount and frequency of nicotine use, time since the last dose, route of administration, genetic metabolism, liver function, kidney function, pregnancy and exposure to other substances. One value cannot precisely determine the number of cigarettes smoked.

Why Is the Test Performed?

A doctor, surgeon, transplant team, occupational-health service or tobacco-cessation programme may request quantitative serum nicotine-metabolite testing for a specific clinical or administrative purpose. Common applications include:

• Confirming recent exposure to nicotine-containing products.
• Supporting verification of smoking or nicotine abstinence.
• Monitoring progress during a tobacco-cessation programme.
• Assessing possible secondhand tobacco-smoke exposure.
• Evaluating nicotine exposure before selected surgical procedures.
• Meeting specific requirements before organ transplantation.
• Providing an objective biomarker when self-reported exposure is uncertain.

The test should be used according to an established clinical or institutional protocol. Cut-off values and abstinence requirements may differ between hospitals, employers, insurers and transplant programmes.

Use Before Surgery

Nicotine and tobacco exposure can affect blood vessels, tissue oxygen delivery, wound healing and postoperative recovery. For selected procedures, particularly reconstructive, plastic, orthopaedic, bariatric or spinal surgery, the surgeon may require a period of nicotine abstinence and laboratory verification before proceeding.

The required abstinence period is determined by the treating team and may be longer than the test's immediate detection window. Patients must disclose nicotine-replacement therapy and vaping because these products can produce positive nicotine and cotinine results even when cigarettes have not been used.

Use in Smoking-Cessation Programmes

Serum cotinine measurement can provide objective information about recent nicotine exposure during a cessation programme. A falling concentration over time may be consistent with reduced exposure, while a low or undetectable result after an appropriate interval may support abstinence.

A positive result should not be used punitively. Nicotine dependence is a medical condition, and patients may benefit from counselling, behavioural support and approved pharmacological treatment. The result should be discussed constructively with the healthcare professional supervising cessation.

Secondhand Smoke Exposure

People who do not actively use nicotine can develop low cotinine concentrations through secondhand tobacco smoke. Exposure may occur at home, work, in vehicles or in other enclosed areas. The level is generally lower than that seen with regular active use, but overlap is possible.

Serum cotinine demonstrates recent exposure and does not identify where or exactly when it occurred. Environmental history and repeat testing may be necessary when low concentrations are unexpected.

What Does the Test Measure?

The exact analytes depend on the laboratory's validated panel. The test may measure cotinine alone or quantify nicotine together with cotinine and selected additional metabolites. The final report should specify every compound tested and provide method-specific reference information.

Cotinine is normally the primary marker because it persists longer than nicotine. A nicotine concentration may fall rapidly after the last exposure, while cotinine remains detectable for several days. In some individuals, cotinine may be detectable for up to approximately seven days, and heavy or chronic users may require longer to reach concentrations comparable with unexposed people.

Which Nicotine Sources Can Produce a Positive Result?

A positive serum nicotine-metabolite result can follow exposure to:

• Cigarettes, bidis, cigars and pipes.
• Chewing tobacco, snuff and other smokeless tobacco.
• Nicotine-containing e-cigarettes or vaping liquids.
• Nicotine pouches.
• Nicotine patches, gum, lozenges, inhalers or sprays.
• Secondhand tobacco smoke.
• Other nicotine-containing products.

The test confirms biochemical exposure to nicotine but usually cannot distinguish tobacco use from purified nicotine-replacement therapy. Additional urine testing for tobacco alkaloids such as anabasine may sometimes help, although that test also has limitations and must be interpreted carefully.

Sample Requirements

The test requires serum obtained from a venous blood sample. Blood is generally collected into a red-top tube or serum separator tube according to laboratory instructions. After the blood clots, the specimen is centrifuged and the serum is transferred to an appropriate transport container.

The collection team should follow the laboratory's requirements for sample volume, tube type, storage temperature and transportation. The time and date of collection should be documented because the interval since the last nicotine exposure is essential for interpretation.

Is Fasting Required?

Fasting is generally not required for serum nicotine-metabolite testing unless another investigation collected at the same time requires fasting. Patients should follow the specific instructions given by their doctor or diagnostic centre.

Patients should not deliberately use or avoid a prescribed nicotine-replacement product contrary to medical advice merely to alter the result. The healthcare professional should be informed about all nicotine-containing products and when they were last used.

Information to Provide Before Testing

For accurate interpretation, provide information about:

• The type of tobacco, vaping or nicotine product used.
• The date and time of the last exposure.
• Frequency and approximate amount of use.
• Nicotine patches, gum, lozenges, sprays or other replacement therapy.
• Possible secondhand smoke exposure.
• The reason for testing and required institutional cut-off.
• Relevant liver or kidney disease.

Not disclosing nicotine-replacement therapy can lead to incorrect assumptions that a positive result proves tobacco smoking.

How Is the Test Performed?

Serum nicotine and its metabolites may be measured using liquid chromatography combined with tandem mass spectrometry. This method separates the target compounds from other substances and provides quantitative concentrations, commonly reported in nanograms per millilitre.

Different laboratories may measure different metabolite combinations and apply different reporting thresholds. Results obtained from separate assay methods should not automatically be compared as though they were identical. Serial monitoring is most consistent when performed using the same laboratory and method.

Understanding the Results

The report provides numerical concentrations with laboratory-specific reference values or interpretive categories. The doctor considers the measured analytes, timing of the last exposure, product used and reason for testing.

Positive or Elevated Result

A positive or elevated nicotine-metabolite result indicates recent exposure to nicotine. Regular active users generally have higher cotinine levels than people exposed only to secondhand smoke, but there is no universal concentration that perfectly separates every active user from every passively exposed person.

Nicotine-replacement therapy and nicotine-containing vaping products can produce concentrations similar to other nicotine sources. Therefore, a serum result alone should not be described as proof of cigarette smoking when alternative nicotine exposure is possible.

Low-Level Cotinine Result

A low cotinine concentration may reflect passive exposure, occasional use, recent cessation, a low-dose nicotine product or biological variation. Dietary sources can contain trace nicotine, but concentrations are generally much lower than those produced by regular nicotine use.

When an institutional decision depends on a low-level result, the ordering team may consider exposure history, repeat testing and an alternative specimen such as urine. The laboratory's cut-off and measurement uncertainty should also be reviewed.

Negative Result

A negative result means that the tested nicotine metabolites were below the method's reporting threshold at the time of collection. It may support recent abstinence but cannot establish lifelong non-use or exclude exposure outside the test's detection window.

Nicotine clears rapidly, and cotinine declines over several days. A person who stopped sufficiently long before collection may have a negative result despite previous use. The result should be interpreted only for the relevant recent period.

How Long Is Nicotine Detectable?

Nicotine itself has a short half-life and may become undetectable relatively quickly. Cotinine persists longer and may remain measurable in serum for several days. Detection time depends on previous use, dose, frequency, metabolism and assay sensitivity.

Many chronic users who completely abstain for approximately two weeks reach nicotine and cotinine concentrations comparable with unexposed individuals. This is a general observation rather than a guaranteed clearance time for every person. The required abstinence period should be determined by the requesting programme.

Serum Versus Urine Testing

Serum testing provides a quantitative assessment of circulating nicotine exposure. Urine often contains higher metabolite concentrations and may offer a longer detection window. Urine panels may also include anabasine or trans-3-hydroxycotinine, which can provide additional information about exposure.

The best specimen depends on the reason for testing. Serum may be preferred for quantitative exposure assessment, while urine may be more useful for detecting nicotine over a longer interval or investigating possible tobacco use during nicotine-replacement therapy.

Limitations of the Test

The test cannot reliably identify the exact nicotine product, number of cigarettes used or precise time of exposure. Results vary because of genetic differences in metabolism, pregnancy, age, liver function, kidney function and medication effects.

Secondhand smoke and nicotine-replacement products can produce positive findings. Cotinine reflects recent exposure rather than long-term lifetime use. A negative result does not exclude earlier exposure, and a positive result does not automatically prove cigarette smoking.

Anabasine testing may help distinguish tobacco from purified nicotine in selected circumstances, but it is not perfectly sensitive or specific. Some electronic-cigarette products and supplements may contain tobacco alkaloids.

Nicotine Metabolite Serum Test at Focus Diagnostics

The Nicotine Metabolite Quantitative - Serum test is available under the pathology and bio-chemistry department at a listed price of ₹2,800. Patients should confirm the measured analytes, specimen requirements, testing schedule and expected reporting time while booking.

Bring the doctor's prescription and any instructions issued by the surgeon, employer, transplant team or cessation programme. Clearly disclose all tobacco, vaping and nicotine-replacement products so that the result can be interpreted correctly.

Important Patient Instructions

• Fasting is generally not required unless otherwise instructed.
• Record the date and time of the last nicotine exposure.
• Disclose nicotine patches, gum, lozenges, pouches and vaping products.
• Do not alter prescribed cessation treatment without medical advice.
• Discuss the result using the cut-off required for its intended purpose.

Medical Disclaimer

This information is intended for general education and does not replace medical or programme-specific advice. Serum nicotine-metabolite testing indicates recent exposure but does not independently identify the product used or prove cigarette smoking. Results require interpretation by the requesting healthcare professional.